Robert Kramer - President and CEO, Director at Emergent BioSolutions Inc.

Issuer-level insider activity

Role
President and CEO, Director
Issuer ticker
EBS on NYSE
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Robert Kramer since 13 Sep 2025

Reported holdings for Robert Kramer in Emergent BioSolutions Inc.

Form 4 holding President and CEO, Director

Emergent BioSolutions Inc.

Security class
Common Stock
Shares / value
506,059
Estimated value
$921,027
Report date
09 Jun 2023
Price
$1.82
Ownership
Direct
Form 4 holding President and CEO, Director

Emergent BioSolutions Inc.

Security class
Employee Stock Option (Right to buy)
Shares / value
535,051
Estimated value
Report date
09 Jun 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Robert Kramer in Emergent BioSolutions Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .